|
Post by jongaltiii on Jul 31, 2021 1:07:46 GMT
Sea of red today in my funds column. Only green was FXNAX - a bond index fund no less.
Ill timed investments (small but still) in these two funds have resulted in YTD:
ARTYX: -7.44% FSEAX: -14.84%
I guess when compared to MACGX at -17.60% YTD I should be happy. But… I’m having a hard time justifying staying with these 2. Anyone have an opinion on their future trajectory? We know what’s happening in China but I wasn’t expecting FSEAX to be so negatively affected.
|
|
|
Post by chang on Jul 31, 2021 1:20:11 GMT
Sea of red today in my funds column. Only green was FXNAX - a bond index fund no less. Ill timed investments (small but still) in these two funds have resulted in YTD: Looks like the first plague on Egypt here, too. However, DODIX (D&C Income), FSMEX (Fido Medical Tech & Equip), FICDX (Fico Canada), JENSX (Jensen Growth), and VWIAX (VG Wellesley) managed to stay in the green. With regard to ARTYX and FSEAX, my opinion (which is worth what you paid for it) is that we are experiencing normal consolidation plus news-driven fear. Where's the breakdown in fundamentals? I'm holding APDYX and MIAPX/MITEX. MS funds are all super high-octane, so nothing should surprise you with them.
|
|
|
Post by jongaltiii on Jul 31, 2021 1:28:22 GMT
You’re right FSMEX was also green today - up 1.05. There’s a reason to be happy. Yes you are so right about MS funds. I’m starting to see MGGPX dip consistently too. MIAPX is still in the green YTD- that’s something. Thanks for the feedback.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 31, 2021 1:39:05 GMT
I replaced FSEAX by DODEX but I am down 7% on DODEX since I bought it. I bought it right at peak.
I sold JPM Emerging markets fund and replaced it by Fidelity Overseas right before this China correction.
I sold BABA and BIDU and not planning to buy any Chinese ADRs in future.
I am continuing with ARTYX. I am up on FEMKX and ARTYX.
I will give EM - DODEX (Dodge & Cox EM), FEMKX (Fidelity EM) and ARTYX - till middle of next year at most.
American Funds New World is long time holding of mine that will continue as dedicated core EM holding.
Not sure how long to stay with losing funds and sectors. I over stayed with Value and it is hurting quite a bit. Value had like 6 months in sun in last 12 years.
|
|
|
Post by jongaltiii on Jul 31, 2021 1:59:24 GMT
@waffle good points. I suppose if I was committed to EM for the next few years… I might also take a look at WSIEX which has a nice consistent record over 5 years. Time will tell. The plain ole SPY sure is looking good these days.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 31, 2021 2:14:13 GMT
I could not find WSIEX. Did you mean Weiss Alternative Multi-Strategy Fund Class K WEISX
|
|
|
Post by jongaltiii on Jul 31, 2021 2:40:06 GMT
WIESX … Wasatch EM Select … dyslexia again… oops.
|
|
|
Post by anitya on Jul 31, 2021 2:47:19 GMT
Sea of red today in my funds column. Only green was FXNAX - a bond index fund no less. Ill timed investments (small but still) in these two funds have resulted in YTD: Looks like the first plague on Egypt here, too. However, DODIX (D&C Income), FSMEX (Fido Medical Tech & Equip), FICDX (Fico Canada), JENSX (Jensen Growth), and VWIAX (VG Wellesley) managed to stay in the green. With regard to ARTYX and FSEAX, my opinion (which is worth what you paid for it) is that we are experiencing normal consolidation plus news-driven fear. Where's the breakdown in fundamentals? I'm holding APDYX and MIAPX/MITEX. MS funds are all super high-octane, so nothing should surprise you with them. FSEAX - I being new to emerging markets investment and now with time to follow investments more closely, I am starting to question Fidelity's emerging markets prowess. Since Feb 19 (2021 peak) FHKCX is down 21% as of today; FSEAX did not do a whole lot better - where is the benefit of country diversification? - China funds from other fund families have done better than FSEAX. Neither of these funds is participating in the China equity market recovery.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 31, 2021 2:48:34 GMT
Thank You. I will look into replacing ARTYX (or may be FEMKX too) with WIESX. They are all growth. And WIESX has some momentum.
DODEX is Value.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jul 31, 2021 2:51:34 GMT
FSEAX is 48% China. That was one of the reasons I got out of it other was I was buying DODEX in same account and did not want too many EM Funds.
|
|
|
Post by oldskeet on Jul 31, 2021 12:06:01 GMT
Hi guys, According to a recent Xray analysis of my portfolio emerging markets make up about 7% of my equity allocation with my two emerging market funds being NEWFX and DWGAX (American Funds). Combined they make up about half of my E/M exposurer. For the month DWGAX is down -4.50% and NEWFX is down -2.75%. For the long haul I am up in both these funds with no plans to trim or sell them. For me, being mostly a buy and hold investor, emerging markets are part of my overall asset allocation; and, I wish to keep my exposurer in them. Old_Skeet
|
|
|
Post by jongaltiii on Jul 31, 2021 23:59:28 GMT
Should you stick with emerging markets? Advisers weigh in… via Marketwatch www.marketwatch.com/story/should-you-stick-with-emerging-markets-advisers-weigh-in-11627647868Summary: If you hold an “emerging markets” stock fund in your IRA or 401(k), it’s been a white-knuckle few days. AGAINST: Ian Weinberg, a financial planner at Family Wealth & Pension in Woodbury, N.Y., gives the case against. Emerging markets—and even developed international markets such as Europe and Japan—give you more risk and less return, he says. “Foreign equities have high correlation to U.S. equities in falling U.S. markets, and then have lower correlation to U.S. markets when they are rising,” he tells me. “That means simply that foreign stocks have begun to provide poor risk and return characteristics. Would you invest in something that goes down as much or more than domestic stocks, and goes up less than domestics stocks when they’re running?” FOR Ordinary investors should absolutely have a weighting toward emerging markets within their long-term investment strategy,” agrees Jay Karamourtopoulos, a financial planner in Boston. “While global economies are now more connected than ever, there are still diversification benefits to investing in emerging markets,” he says. He adds: “Most investors have a home country bias to begin with. Couple that with the strong U.S. returns over the past decade and an argument can be made that many individual investors are severely overweight domestic stocks.” Mention of Buffet advising to just play the US market as well with 90 percent in domestic market and 10 in treasuries
|
|